92 related articles for article (PubMed ID: 2662053)
1. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Camus A; Rose C; Schwartz JC
Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
[TBL] [Abstract][Full Text] [Related]
2. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Rose C; Camus A; Schwartz JC
Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
[TBL] [Abstract][Full Text] [Related]
3. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
Rose C; Camus A; Schwartz JC
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8326-30. PubMed ID: 3186727
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.
Checler F; Emson PC; Vincent JP; Kitabgi P
J Neurochem; 1984 Nov; 43(5):1295-301. PubMed ID: 6387047
[TBL] [Abstract][Full Text] [Related]
7. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
Konkoy CS; Davis TP
J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
Najdovski T; Collette N; Deschodt-Lanckman M
Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
10. Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8).
Matsas R; Turner AJ; Kenny AJ
FEBS Lett; 1984 Sep; 175(1):124-8. PubMed ID: 6090206
[TBL] [Abstract][Full Text] [Related]
11. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the metabolism of CCK8 analogues by rat brain slices.
Durieux C; Charpentier B; Pelaprat D; Roques BP
Neuropeptides; 1986 Jan; 7(1):1-9. PubMed ID: 3456492
[TBL] [Abstract][Full Text] [Related]
14. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
Lentzen H; Palenker J
FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
[TBL] [Abstract][Full Text] [Related]
15. A radioimmunoassay for the tripeptide Gly-Trp-Met, a major metabolite of endogenous cholecystokinin in brain.
Rose C; Vargas F; Bourgeat P; Schwartz JC
Neuropeptides; 1996 Jun; 30(3):231-5. PubMed ID: 8819147
[TBL] [Abstract][Full Text] [Related]
16. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cholecystokinin metabolism by membrane preparations from the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
Medeiros Mdos S; Turner AJ
Neurochem Int; 1994 Apr; 24(4):369-77. PubMed ID: 7914787
[TBL] [Abstract][Full Text] [Related]
18. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
Steardo L; Knight M; Tamminga CA; Chase TN
Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
[TBL] [Abstract][Full Text] [Related]
20. Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
